Biogen Inc. (BIIB) Presents at Piper Sandler Virtual Novel Targets in Immunology Symposium Transcript

PresentationDavid AmsellemPiper Sandler & Co., Research Division Okay, good morning, everyone. And as I keep saying this morning, happy Friday the 13th, but on a serious note, we're delighted to be hosting our Virtual Immunology Symposium. This is David Amsellem from the Piper Sandler Biopharma Research Team. And we're delighted to have Biogen with us for the next 25 minutes or so. So we have Dr. Diana Gallagher. She is the Head of Clinical Development for MS Immunology and Alzheimer's. So thanks so much, D ...